Esperion Therapeutics(美国)

Esperion Therapeutics

EsperionTherapeuticswww.esperion.com生物制药公司，专注于研究，开发和商业化的低密度脂蛋白胆固醇（LDL-C）水平升高和其他心血管代谢危险因素的患者的治疗疗法。EsperionTherapeutics,Inc.isaleaderinthedevelopmentandcommercializationoforal,smallmoleculetherapiesfort hetreatmentofpatientswithelevatedlevelsoflow-densitylipoproteincholesterol(LDL-C)andothercardiometabolicriskfactors.ETC-1002,Esperion’sleadproductcandidate,isanovel,first-in-class,orallyavailable,once-dailyLDL-CloweringsmallmoleculetherapydesignedtotargetknownlipidandcarbohydratemetabolicpathwaystolowerlevelsofLDL-CandtoavoidmanyofthesideeffectsassociatedwithexistingLDL-Cloweringtherapies.ETC-1002istargetedforstatin-intolerantpatientswithelevatedlevelsofLDL-C.